FDA Advisory Committee Recommends Against Approving Tarceva For First-Line Maintenance Use In Advanced Non-Small Cell Lung Cancer (source: Medical News Today)

« Researchers find high leptin levels may protect against Alzheimer’s disease and dementia (source: Science Daily)

Accelerated aging: Researchers identify traits of people with rare syndrome (source: Science Daily) »

FDA Advisory Committee Recommends Against Approving Tarceva For First-Line Maintenance Use In Advanced Non-Small Cell Lung Cancer (source: Medical News Today)

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG)(OTCQX: RHHBY), announced that the U.S… (source: Medical News Today) – News widgets and RSS feeds on Feedzilla.com

Tags:breast cancer,colon cancer,health and beauty products,liver cancer,lung cancer,ovarian cancer,skin cancer,Womens Health

Health and Beauty Products Mall

FDA Advisory Committee Recommends Against Approving Tarceva For First-Line Maintenance Use In Advanced Non-Small Cell Lung Cancer (source: Medical News Today)

Leave a Reply